Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Location-based method to specify ratio frequency spectrum rights
Method for using directing cells for specific stem/progenitor cell activation and differentiation
Method of motion correction in optical coherence tomography imaging
Temporary protective cover for an exposed junction box
Using network labels without standard-defined syntax and semantics
Method and apparatus for monitoring for a radio link failure
System and method for detecting deadlock in a multithread program
  Randomly Featured Patents
Electrical connection box
Bulk input current switch logic circuit
Coffee preparation scoop
Toy monorail vehicle
Apparatus for severing the meat from bones
Speaker grill
Stroller in combination with a safety seat assembly
Hot within my communities
Safety covering for an airbag
Three-dimensional image processing apparatus with enhanced automatic and user point of view control